Abbott, CamDiab and Ypsomed today announced that they are partnering to develop and commercialize an integrated automated insulin delivery (AID) system to help lessen the burden of round-the-clock diabetes management for people with diabetes. The initial focus of the partnership will be in European countries. The new integrated AID system is being designed to connect…
从这篇文章中可以得到什么：
- The initial focus of the partnership will be in European countries.
- Abbott, CamDiab and Ypsomed today announced that they are partnering to develop and commercialize an integrated automated insulin delivery (AID) system to help lessen the burden of round-the-clock diabetes management for people with diabetes.
- The new integrated AID system is being designed to connect….
